close
close

GNW-Adhoc: Simtra BioPharma Solutions appointed Dr. Lidia Serina as Head of Development Services | 27.08.24

GNW-Adhoc: Simtra BioPharma Solutions appointed Dr. Lidia Serina as Head of Development Services | 27.08.24

^PARSIPPANY, New Jersey, August 27, 2024 (GLOBE NEWSWIRE) — Simtra BioPharma

Solutions, a fuhrendesentwicklungs- und Productionsunternehmen

(Contact Development and Manufacturing Organization, CDMO), the sterile

Special syringes are specialized in the treatment of Dr. Lidia

Serina, Ph.D., voor Leiterin der Entwicklungsabteilung bekanntzugeben.

Dr. Serina has been working in the world for more than 25 years

Pharmaceutical industry and leading companies in Europe and North America

inn. There is a new version of the pharmaceutical industry in the pharmaceutical sector, which for

your strategic vision, your personal development and your comprehensive vision

The best part is that the high demands in large teams lead to complex and intricate teams

herausfordernden Bedingungen voranzutreiben.

Vor ihrem Eintritt at Simtra war Dr. Serina Vice President and Visp Biologics

Site Head at Lonza AG in Switzerland and with other leading positions

at Curevac, GlaxoSmithKline and Sanofi Pasteur in den Bereichen

Impfstoffforschung en -entwicklung, qualitative conformität, pharmaceutical

Recovery and Lieferkettenmanagement inne.

Ray Guidotti, Chief Operating Officer of Simtra BioPharma Solutions,

Kommentierte de Ernennung who follows:?Wir freuen uns sehr, Dr. Lidia Serina in

unserem Fuhrungsteam begrüßen zu dürfen. There is a failed fault in der

Pharmaceutical industry and its emerging food financing market

operator Exzellenz und kommerziellem Wachstum machen are zur idealen

Führungskraft voor de Leitung offers Geschäftsbereichs Development Services.

Unter der Führung von Dr. Serina since we are in the clear, that is what we are doing

clinical trials are being conducted and no longer conducted

“Wachstumsziele erreichen können.”

Dr. Serina said that she, Simtra beizutreten:?I am happy, Simtra

BioPharma Solutions in such a separated phase blessing Wachstumsgeschichte

beizutreten. I am having fun with the talent of Team von Simtra

In summary, one of our Entwicklungsdienstleistungen weiter zu improven

and innovative walking with love, who cannot miss their walking beds

Customers are entitled.”

Dr. Serina holds a PhD in Biochemistry from the University of Paris 7 and

the Pasteur Institute and his postdoc training in Krebsgenetik am Cold

Spring Harbor Laboratory closed down.

Simtra BioPharma Solutions is one of the best suppliers of pharmaceutical and pharmaceutical products

Biotechnology companies are involved in the development of a

invisible products and a repair process that can be repaired, damn

it is a quality product on the market that brings a product to the market

improvements could be made. With the understanding of Dr. Serina is the Unternehmen gut

upgraded, a number of Success Courses and Seine Innovation Power on the market for

sterile injection preparation fortuses.

For more information, please contact: Rhonda Luniak, Director of

Communications, Simtra BioPharma Solutions, [email protected]

(mailto:[email protected]), 303.406.8743

Über Simtra BioPharma Solutions:

If you make a mistake, you can leave the lung and production units with non-pending

more than 65 years of experience in repair sterilizer injection molding

Simtra BioPharma Solutions premium cGMP compliant sterile suction and

Finishing work, technical know-how, high service and one

A joint collaboration with the strategic vision

our customers.

Biotechnology and pharmaceutical companies collaborate with one of them, if they do

Bringing molecules to market wool, things, an innovation world

fill out a form or take proactive action

minimize, um ihr Geschäft auszubauen.

Our teams of long-standing experts are large, flexible

Problems, you can help us improve your product and in

high quality of care, damned in the hands of patients,

they are most urgently needed.

°